The eRNAs inducing oncogene expression can be considered as potential therapeutic targets, as for instance CCAT1, which directly drives MYC expression in colorectal cancer [62] or other eRNAs specifically transcribed at MYC super-enhancer in hepatocellular carcinoma [63]. This evidence concerns the gene MYC and colorectal cancer.